Welcome to Tech Beat, your daily read on the stories shaping our digital world.
DeepSeek is back, and the timing couldn't be more pointed. The Chinese AI startup has released DeepSeek-V four, delivering near state-of-the-art performance at roughly one-sixth the cost of leading American models. It's another reminder that the gap between open and proprietary AI is closing faster than many in Silicon Valley would like to admit.
That cost pressure lands in an already uncomfortable moment for the industry. A new piece in The New Republic argues that public sentiment toward AI has curdled significantly, with backlash growing across concerns about jobs, trust, and the sheer pace of deployment. The industry built its pitch around inevitability, and it turns out inevitability doesn't poll well.
On a quieter but genuinely fascinating note, researchers publishing in Science have found that mechanical load, essentially the physical stress the heart muscle endures with every beat, appears to inhibit cancer cell growth in both mouse and human cardiac tissue. It's early work, but it raises intriguing questions about what the body's own forces might teach us about fighting disease.
That's where things stand today. Keep surfing. Tech Beat out.
